Drug Type Oncolytic virus |
Synonyms MVR-T7012 |
Mechanism CCL5 inhibitors(C-C motif chemokine 5 inhibitors), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), IL-12 modulators(Interleukin-12 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | CN | 12 Feb 2022 |